October 14, 2016
As reported in the latest US Food and Drug Administration (FDA) Enforcement Report, a voluntary recall of 1-mg PredniSONE tablets USP was initiated by West-Ward Pharmaceuticals on October 3. This nationwide, Class II recall is ongoing.
The reasons cited for this recall of more than 15,000 100-count bottles of the prescription drug are “failed tablet/capsule specifications: discovery of an underweight tablet.”
The recalled PredniSONE tablets have an expiration date of January 31, 2018 and a lot number of 660621A.
The drug is indicated for the treatment of endocrine disorders, rheumatic disorders, and collagen diseases, among others.
—Meredith Edwards White